This was particularly true for HER2-enriched tumors and triple-negative tumors, which have been more closely associated with aggressive tumor features, such as increased tumor size, positive lymph nodes, and lymphovascular invasion [34]. This evidence concerns the gene ERBB2 and neoplasm.